v3.24.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities    
Net loss $ (1,303,903) $ (6,336,374)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 368,301 530,830
Gain on disposal of property and equipment (3,547)
Noncash lease expense 193,281 197,198
Bad debt expense 11,964 4,510
Share-based compensation 7,557 39,842
Income tax expense 70,751
Interest expense paid in equity shares 32,145
Accounts payable paid in equity shares 40,000
Accrued interest on notes payable 327,132 528,100
Non-cash royalty income (13,282)
Amortization of original issue discounts on notes payable 441,734
Amortization of loan origination costs 18,133
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Trade receivables (696,824) (1,541,371)
Trade receivables - related party (163,349) (383,710)
Inventory 800,602 (116,942)
Contract assets 45,066 (260,647)
Prepaid expenses and other current assets 636,906 (410,327)
Other assets (54,592) (146,356)
Accounts payable (2,072,392) (327,945)
Accounts payable - related party 221 (99)
Sales tax payable (25,116) (2,387)
Operating lease liabilities (193,130) (132,963)
Deposits from customers 26,179 416,523
Accrued expenses (941,698) 977,328
Contract liabilities 8,406 1,037,897
Deferred revenue (54,982) (95,395)
Income taxes payable (78,574) (94,848)
Other liabilities (95,730) (225,506)
Net cash used by operating activities - continuing operations (3,139,073) (5,872,310)
Net cash provided by operating activities - discontinued operations 2,501,426
Net cash used by operating activities (3,139,073) (3,370,884)
Cash Flows from Investing Activities    
Purchase of property and equipment (290,666) (571,658)
Proceeds from sale of property and equipment 3,547
Proceeds from sale of marketable securities 356
Investment in MasterpieceVR (100,000)
Net cash used by by investing activities - continuing operations (390,310) (568,111)
Net cash provided by investing activities - discontinued operations 207,329
Net cash used by investing activities (390,310) (360,782)
Cash Flows from Financing Activities    
Proceeds on revolving line of credit 11,655,935
Payments on revolving line of credit (8,371,144)
Payments on debt (2,204,743) (294,370)
Payments on Paycheck Protection Program Loans (10,120)
Proceeds on bank loans 28,331
Payments on bank loans (100,160) (306,550)
Net cash provided by/(used by) financing activities 998,099 (600,920)
Effect of currency translation 198,454 229,243
Net decrease in cash, cash equivalents, and restricted cash (2,531,284) (4,332,586)
Less cash attributed to discontinued operations (714,420)
Cash, cash equivalents, and restricted cash at beginning of period 6,349,562 12,188,096
Cash, cash equivalents, and restricted cash at end of period 4,016,732 7,370,333
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and cash equivalents 2,835,216 5,768,610
Restricted cash 1,181,516 1,601,723
Total cash, cash equivalents, and restricted cash 4,016,732 7,370,333
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 238,418 126,255
Cash paid during the period for income taxes, net of refunds 176,378 94,848
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Shares issued to pay for services 40,000
Shares issued to pay notes payable 232,145
Financing of fixed asset purchase 28,331
Investment in right of use asset $ 76,506

Source

PDF HTML
ZIP XBRL